Predict your next investment

Corporation
HEALTHCARE | Biotechnology
cubist.com

See what CB Insights has to offer

Founded Year

1992

Stage

Acquired | Acquired

Total Raised

$13M

Valuation

$0000 

About Cubist Pharmaceuticals

Cubist Pharmaceuticals is a pharmaceutical company developing novel antimicrobial drugs.

Cubist Pharmaceuticals Headquarter Location

65 Hayden Avenue

Lexington, Massachusetts, 02421,

United States

781-860-8660

Latest Cubist Pharmaceuticals News

Poxel hires Elizabeth Woo to lead PR, corporate comms and IR

Sep 7, 2021

Her industry experience includes working at Biogen, Flex Pharma, Ironwood and Cubist. by Betsy Kim / Added 1 hour ago Woo will work closely with the company’s leadership team. (Photo credit: Getty) BOSTON: Poxel, a clinical stage biopharmaceutical company, has appointed Elizabeth Woo as SVP of IR, PR and corporate communications. Based in the Boston area, she will work closely with the company’s leadership team, headquartered in Lyon, France. Poxel CEO Thomas Kuhn in a release noted Woo’s extensive experience working with the biotech financial community and strong track record in raising the visibility of biopharmaceutical companies in the U.S. Woo has 25 years of industry experience, covering strategic investor and corporate communications, spanning the full life cycle of drug development and commercialization. Most recently, she served as a biotech investor relations consultant for Kendall Investor Relations. Woo began her career at Biogen, a Cambridge, Massachusett-based company that specializes in developing therapies to treat neurological diseases. She worked for 12 years as VP of investor relations. Subsequently, as an IR consultant, she advised the publicly traded company Ironwood Pharmaceuticals, whose research focuses on gastrointestinal diseases and Cubist Pharmaceuticals, whose work targets pathogens like MRSA. Woo then, for four years, took on the role of SVP of corporate comms and investor relations at Flex Pharma, a clinical-stage biotech firm that researches treatments for neurological conditions. Poxel, which is listed on Euronext Paris, develops treatments for serious, chronic metabolic diseases. It reported revenue of €13.3 million ($15.8 million) for the six months ended June 30, 2021, compared to €6.4 million ($7.6 million) during the corresponding period in 2020.

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Cubist Pharmaceuticals

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Cubist Pharmaceuticals is included in 2 Expert Collections, including Pharma Startups.

P

Pharma Startups

11,639 items

Pharmaceutical companies working across drug discovery, drug development and drug manufacturing.

I

Infectious Disease

2,226 items

Entities aiding the surveillance, screening, prevention, diagnosis, treatment, and containment of infections & the maintenance of public wellbeing during outbreaks.

Cubist Pharmaceuticals Patents

Cubist Pharmaceuticals has filed 65 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

1/21/2014

7/19/2016

Ion channels, G protein coupled receptors, Membrane biology, Analgesics, Neurological disorders

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

1/21/2014

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

7/19/2016

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Ion channels, G protein coupled receptors, Membrane biology, Analgesics, Neurological disorders

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.